1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA FAH CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA CDH24 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA ZFP1 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA ZIC5 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA ZFPL1 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA NEURL4 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA NRXN1 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA KDM1A CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA LINGO1 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA DYM CTRPv2 pan-cancer AAC 0.15 2e-05
Download CSV